Related Experiment Video
Updated: Aug 22, 2025

Fast and Specific Assessment of the Halogenating Peroxidase Activity in Leukocyte-enriched Blood Samples
Published on: July 28, 2016
Myeloperoxidase as a Potential Biomarker of Acute-Myocardial-Infarction-Induced Depression and Suppression of the
Andreas Baranyi1, Dietmar Enko2, Andreas Meinitzer2
1Division of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, 8036 Graz, Austria.
Abstract:
While myeloperoxidase (MPO) serves as an indicator of both neutrophil and innate-immune-system function, the potential suppression of the innate immune system in patients with acute myocardial infarction (AMI)-induced depression might be evidenced by a decrease in MPO serum levels. The aim of this prospective study was to (1) determine whether serum concentrations of MPO vary immediately and 6 months after AMI and (2) to investigate whether MPO concentrations at the time of the AMI are significant predictors of AMI-induced depression and the depression-associated suppression of the innate immune system. A total of 109 AMI patients were assessed with the Hamilton Depression Scale (HAMD-17) immediately after admission to the hospital and 6 months later. The MPO status was assessed with serum samples, which were also collected immediately and 6 months after AMI. The depressive patients showed significantly lower MPO blood levels immediately and 6 months after the AMI compared to the patients without depression (ANCOVA: MPO (depression) F = 4.764, df = 1, p = 0.031). The baseline MPO was observed as a significant predictor (p = 0.027) of AMI-induced depression 6 months after AMI. MPO is a potential biomarker for AMI-induced depression, indicating a depression-associated suppression of the innate immune system.
Insights
Myeloperoxidase (MPO) levels decrease in patients experiencing depression after acute myocardial infarction (AMI). Lower baseline MPO predicts future depression, suggesting MPO as a biomarker for AMI-induced depression and immune suppression.
Area of Science:
- Immunology
- Cardiology
- Psychiatry
Background:
- Myeloperoxidase (MPO) indicates neutrophil and innate immune function.
- Acute myocardial infarction (AMI) can lead to depression, potentially involving immune system suppression.
- Decreased MPO serum levels may indicate this immune suppression in AMI patients.
Purpose of the Study:
- To assess MPO serum concentration changes immediately and 6 months post-AMI.
- To determine if MPO levels predict AMI-induced depression and immune suppression.
Main Methods:
- Prospective study of 109 AMI patients.
- Assessed depression using Hamilton Depression Scale (HAMD-17) at admission and 6 months.
- Measured serum MPO levels at the same time points.
Main Results:
- Depressive patients had significantly lower MPO levels immediately and 6 months post-AMI.
- Baseline MPO levels were a significant predictor of depression 6 months after AMI (p=0.027).
Conclusions:
- MPO is a potential biomarker for AMI-induced depression.
- Lower MPO levels suggest a depression-associated suppression of the innate immune system in AMI patients.
More Related Videos
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests